BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 582538)

  • 21. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General pharmacology of pergolide in animals. 2nd communication: gastrointestinal, renal and miscellaneous studies.
    Williams PD; Bendele A; Deldar A; McGrath J; Shetler T; Owen N
    Arzneimittelforschung; 1992 Jul; 42(7):891-5. PubMed ID: 1418052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroprotective activity of ferruginol in mice and rats: effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls.
    Areche C; Theoduloz C; Yáñez T; Souza-Brito AR; Barbastefano V; de Paula D; Ferreira AL; Schmeda-Hirschmann G; Rodríguez JA
    J Pharm Pharmacol; 2008 Feb; 60(2):245-51. PubMed ID: 18237473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Double-blind evaluation of the effectiveness of lidamidine hydrochloride (WHR-1142A) vs loperamide vs. placebo in the treatment of acute diarrhea].
    Heredia Díaz JG; Kajeyama Escobar ML
    Salud Publica Mex; 1981; 23(5):483-91. PubMed ID: 7036368
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimotility and antisecretory activity of some aryl substituted amidinoureas.
    Douglas GH; Diamond J; Studt WL; Mir GN; Alioto RL; Auyang K; Burns BJ; Cias J; Darkes PR; Dodson SA; O'Connor S; Santora NJ; Tsuei CT; Zalipsky JJ; Zimmerman HK
    Arzneimittelforschung; 1978; 28(8a):1435-41. PubMed ID: 582534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of the novel antimuscarinic agent 4-[2-(1,2-benzisoxazol-3-yl)-2-(hexahydro-1H-azepin-1-yl)a cetoxy]-1-et hyl-1- methylpiperidinium iodide.
    Kawashima K; Yoshida N; Kadokawa T
    Arzneimittelforschung; 1986 Jun; 36(6):927-35. PubMed ID: 3741526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The local anaesthetic activity of a benzotriazinium salt.
    French AM; Khan MT; Scott NC
    Br J Pharmacol; 1978 Jul; 63(3):475-9. PubMed ID: 307423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New antihypertensive agent, DL (methylene-dioxy-3-4) phenyl 2 hydroxy-2-acetamidine hydrochloride (LL 1418). Toxicity; general properties].
    Duteil J; Sautal M; Montagne J; Pessonnier J; Gombert R; Assous E
    Therapie; 1969; 24(4):711-21. PubMed ID: 5822009
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
    Hoshina K; Yamazaki N; Takeshita T; Naruchi T
    Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of gastric acid secretion by a standardized aqueous extract of Cecropia glaziovii Sneth and underlying mechanism.
    Souccar C; Cysneiros RM; Tanae MM; Torres LM; Lima-Landman MT; Lapa AJ
    Phytomedicine; 2008 Jun; 15(6-7):462-9. PubMed ID: 18462931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.
    Gasbarrini G; Corazza GR; Feliciani M; Albano O; Stufano N; Altomare E; Fontana G; Valpiani D; Chiodo F; Banterle C
    Arzneimittelforschung; 1986 Dec; 36(12):1843-5. PubMed ID: 3551969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of dihydroxy-dibutylether, a specific choleretic drug.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1976; 26(11):2116-24. PubMed ID: 1037259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
    Okabe S; Tabata K; Kawakami M
    Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.